Danaher (DHR), Cryoport (CYRX), and Sartorius (SARTF) stocks win buy from Guggenheim while Maravai LifeSciences (MRVI) was granted a neutral rating. Read more here.
Dulan Lokuwithana is an Editor specializing in breaking news in the healthcare sector. With a focus on providing timely and accurate information, Dulan covers a wide range of topics including pharmaceutical developments, clinical trials, and market analysis. Dulan's articles aim to keep readers informed about the latest trends and news in the healthcare industry.